Navigation Links
Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects
Date:8/2/2008

Houston-based Law Firm Offers Assistance, Information to People Affected by Dangerous Tysabri Effects.

Houston, TX (PRWEB) August 2, 2008 -- Tysabri side effects lawyers Pulaski & Middleman announce the launch of a http://www.tysabrilawsuitattorney.com [website] dedicated to assisting people who are suffering serious side effects as a result of taking Tysabri (natalizumab).

Tysabri, a drug used to treat multiple sclerosis (MS) and Crohn's disease, is marketed by Irish drug company Elan and US biotechnology firm Biogen Idec.

In 2005, Tysabri was briefly pulled out of the market after three patients participating in clinical trials contracted progressive multifocal leukoencephalopathy (PML), a rare but deadly viral brain infection. Although the drug was eventually re-released, two more cases of PML were reported in mid-2008, raising more concerns about Tysabri's safety and side effects.

The U.S. Food and Drug Administration (FDA) has also warned that Tysabri has the potential to cause serious liver damage leading to death or the need for a liver transplant.

As experienced litigators, http://www.tysabrilawsuitattorney.com [Tysabri lawyers] Pulaski & Middleman stand ready to assist people who have been adversely affected by this potentially dangerous drug.

About Pulaski & Middleman:
A Houston-based law firm, Pulaski & Middleman has successfully resolved thousands of cases and helped countless clients during its 15-year history. They pride themselves in a personal approach to even the most complicated cases, including medical malpractice, product liability, and other areas of personal injury law.

If you or someone you love is suffering from the side effects of Tysabri, contact Pulaski & Middleman at http://www.tysabrilawsuitattorney.com and discuss your case with a Tysabri attorney today.

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1171064.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stopping Tysabri May Worsen MS
2. MS Drug Tysabri Approved for Crohns Disease
3. Tysabri May Cause Liver Damage, Health Officials Say
4. Connecticut Trial Lawyers Ask Doctors to Question Insurers Excess Profits
5. Marin County Scandal and Elder Abuse Horror: Lawsuits Link Death Nurse, Bay Area lawyers, Doctor and Blind Eye by Local, State, and National Public Officials
6. Granholm Looks To Make Big Bucks for Personal Injury Lawyers, Says Michigan Chamber of Commerce
7. Darwin Introduces Enhancements to its Lawyers Professional Liability Insurance Policy Including Privacy Wrongful Acts and More
8. The Case for Trial Lawyers
9. Get Your Fruits & Veggies: CDC
10. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
11. Story ideas from molecular & cellular proteomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... Beleza Medspa has initiated a new program ... is the first time that Coolsculpting is being used for for more than just ... ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... ... 2016 , ... Georgia State University College of Law is ... Answering to the increasing demand for curricular specializations, the Certificate in Intellectual Property ... land use law. ,  , “The demand for lawyers with specific knowledge in ...
(Date:5/26/2016)... ... 2016 , ... There are nearly 14.5 million people living with and beyond ... Sunday, June 5, 2016, communities around the world will gather to recognize these cancer ... Cancer Survivors Day® is an annual worldwide Celebration of Life that is held on ...
(Date:5/26/2016)... ... ... effort to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is ... the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of ... Mohebi says, “The positive response to the Snapchat videos we started last month has been ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... IRVINE, Calif. , May 25, 2016 /PRNewswire/ ... of testing for their new reference materials that ... workflows from sample collection to analyses. The rapid ... the demand for researchers to have standard methods ... data being generated. Biases inherently exist at every ...
Breaking Medicine Technology: